Ịghọta olu coagulation ọbara: oke nkịtị na mkpa ahụike

N'ihe gbasara ahụike ahụike, ọrụ coagulation ọbara bụ njikọ dị mkpa n'ịnọgide na-enwe ọnọdụ ahụ mmadụ nkịtị. Oke coagulation ọbara, nke a na-ejikarị ihe ngosi metụtara coagulation atụ, na-arụ ọrụ dị mkpa n'ikpebi ọnọdụ ahụike nke ahụ mmadụ. Yabụ, kedu ka coagulation ọbara nkịtị si dị? Okwu a metụtara nchọpụta na ọgwụgwọ nke ọtụtụ ndị ọrịa, ọ dọtakwara ọtụtụ ndị ọkachamara ahụike na ọha na eze.

N'ozuzu, ihe ngosi nnwale ọrụ coagulation a na-ejikarị eme ihe n'ọgwụgwọ gụnyere oge prothrombin (PT), oge thromboplastin nke na-arụ ọrụ (APTT), oge thrombin (TT) na fibrinogen (FIB).
Oke nkịtị nke ihe ngosi ndị a bụ:
Oge Prothrombin (PT) na-adịkarị n'etiti sekọnd 10 na 14, ọ dịkwa mkpa n'ihe gbasara ahụike ma ọ bụrụ na ọ gafere njikwa nkịtị karịa sekọnd 3;
Oge a na-arụ ọrụ nke oge thromboplastin nke akụkụ ya (APTT) bụ sekọnd 25 ruo 37, ọ bụrụkwa na ọ gafere njikwa nkịtị karịa sekọnd 10, a ga-ewere ya nke ọma;
Oge thrombin nkịtị (TT) bụ sekọnd 12 ruo 16, ịgafe njikwa nkịtị karịa sekọnd 3 na-egosi na enwere ike inwe nsogbu;
Ọdịnaya nkịtị nke fibrinogen (FIB) dị n'etiti 2 na 4 g/L.

Agbanyeghị, ekwesịrị ịmara na n'ihi ọdịiche dị n'ụzọ nyocha, ihe ndị na-eme ka ọbara gbapụta na ngwa ndị ụlọ ọgwụ dị iche iche na-eji, oke ọbara agbapụta nkịtị nwere ike ịdịtụ iche. Ya mere, oke ọbara agbapụta nkịtị kwesịrị ịdabere na ụdị akụkọ ụlọ ọgwụ ebe a na-agwọ onye ọrịa ahụ.

Oke mkpụkọ ọbara na-adịghị mma na-abụkarị ihe jikọrọ ya na ọtụtụ ọrịa dị iche iche. Mgbe oke mkpụkọ ọbara dị oke elu, ọ nwere ike ịbụ n'ihi ọrịa dịka thrombocytosis, polycythemia vera, na mkpụkọ ọbara na-agbasa n'ime akwara, nke na-eme ka mkpụkọ ọbara dịkwuo elu ma si otú a mee ka ohere nke mkpụkọ ọbara dịkwuo elu. Na mgbakwunye, ụfọdụ ọgwụ dịka ọgwụ mgbochi ọbara (heparin, warfarin), ọgwụ mgbochi platelet (aspirin, clopidogrel), ọgwụ chemotherapy, na ọgwụgwọ dịka hemodialysis na oxygenation nke membrane extracorporeal (ECMO) nwekwara ike imetụta ọrụ mkpụkọ ọbara, na-ebute oke mkpụkọ ọbara. N'ụzọ megidere nke ahụ, ọrụ mkpụkọ ọbara na-adịghị mma nwekwara ike ịbụ nke enweghị mkpụkọ ọbara nke sitere na ihe nketa, enweghị vitamin K, thrombocytopenia, oke ojiji nke ọgwụ mgbochi ọbara, na ọrịa oriri nke ihe na-akpata ...

Maka ọha na eze, ọ dị oke mkpa ịghọta oke olu coagulation nkịtị na ihe ọmụma dị mkpa gbasara ọrụ coagulation na-adịghị mma. Ọ bụrụ na achọpụtara oke coagulation na-adịghị mma n'oge nyocha anụ ahụ ma ọ bụ ọgwụgwọ ahụike, a ga-agakwuru dọkịta n'oge iji kọwaa ihe kpatara ya ma mee usoro ọgwụgwọ kwesịrị ekwesị. N'otu oge ahụ, nyocha anụ ahụ mgbe niile na ịnọgide na-ebi ndụ dị mma na-enyekwa aka n'ịnọgide na-arụ ọrụ coagulation nkịtị.

Beijing Succeeder Technology Inc. (koodu ngwaahịa: 688338) etinyela aka nke ukwuu n'ihe gbasara nchọpụta coagulation kemgbe e guzobere ya na 2003, ma na-agba mbọ ịghọ onye ndu n'ọhịa a. Ụlọ ọrụ ahụ, nke dị na Beijing, nwere otu R&D siri ike, mmepụta na ire ahịa, na-elekwasị anya na imepụta ihe ọhụrụ na itinye teknụzụ nchọpụta thrombosis na hemostasis n'ọrụ.

Site na ike teknụzụ ya pụrụ iche, Succeeder emeriela ikike ikike 45, gụnyere ikike mmepụta ihe 14, ikike ụdị ọrụ 16 na ikike imewe 15. Ụlọ ọrụ ahụ nwekwara asambodo ndebanye aha ngwaahịa ngwaọrụ ahụike 32 nke Klas II, asambodo ntinye akwụkwọ 3 nke Klas I, na asambodo EU CE maka ngwaahịa 14, ma agafeela asambodo sistemụ njikwa mma ISO 13485 iji hụ na ịdị mma na nkwụsi ike nke ngwaahịa.

Succeeder abụghị naanị otu n'ime ụlọ ọrụ dị mkpa nke Beijing Biomedicine Industry Leapfrog Development Project (G20), kamakwa ọ dabara na Sayensị na Teknụzụ Innovation Board na 2020, nke mere ka ụlọ ọrụ ahụ nwee ọganihu dị ukwuu. Ugbu a, ụlọ ọrụ ahụ ewulitela netwọk ahịa mba niile nke na-ekpuchi ọtụtụ narị ndị nnọchi anya na ọfịs. A na-ere ngwaahịa ya nke ọma n'ọtụtụ akụkụ nke mba ahụ. Ọ na-agbasakwa ahịa mba ofesi ma na-eme ka asọmpi mba ụwa ka mma mgbe niile.